# Cannabidiol for Bilateral Total Knee Arthroplasty

> **NCT04749628** · PHASE4 · COMPLETED · sponsor: **Hospital for Special Surgery, New York** · enrollment: 37 (actual)

## Conditions studied

- Pain, Postoperative
- Opioid Use
- Knee Osteoarthritis

## Interventions

- **DRUG:** cannabidiol
- **OTHER:** Ora-sweet SF

## Key facts

- **NCT ID:** NCT04749628
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-02
- **Primary completion:** 2024-10-11
- **Final completion:** 2025-01-08
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04749628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04749628, "Cannabidiol for Bilateral Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04749628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*